Please login to the form below

Not currently logged in
Email:
Password:

Vical

This page shows the latest Vical news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate heads for human studies

Genital herpes vaccine candidate heads for human studies

Last year, Vical abandoned its VCL-HB01 candidate for HSV-2 infections after it failed a mid-stage clinical trial.

Latest news

More from news
Approximately 4 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics